PAQ Therapeutics is a clinical-stage biotechnology company that utilizes autophagy to develop small-molecule KRAS degraders for the treatment of lethal cancers. The company's…
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see PAQ Therapeutics →Already a subscriber? Sign in
Xcout Intel tracks PAQ Therapeutics continuously — this profile deepens as new filings, funding, people and hiring data arrive.
Work at PAQ Therapeutics? Claim this profile